Updates on the Diagnosis and Management of Retinal Diseases
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 227
Special Issue Editor
Interests: retinal diseases
Special Issue Information
Dear Colleagues,
The field of ophthalmology has witnessed monumental advancements in the year 2023, marking it as a pivotal period in the evolution of retinal disease diagnosis and management. In February, a significant milestone was achieved with the Food and Drug Administration (FDA)’s approval of pegcetacoplan, a pioneering therapeutic agent for the treatment of geographic atrophy. This approval, following decades of diligent research and clinical trials, symbolizes a promising horizon in the battle against advanced dry age-related macular degeneration. The path of innovation continued undeterred into September, when the prestigious 2023 Lasker–DeBakey Clinical Medical Research Award was awarded to a trio of visionaries for their seminal invention of optical coherence tomography (OCT). This invention has not only advanced ophthalmic diagnostics but has reshaped the landscape of retinal disease care. OCT, now an indispensable tool in retina clinics, has caused a paradigm shift, facilitating earlier and more accurate diagnoses, thus enabling timely and targeted interventions in managing a variety of retinal diseases, including diabetic retinopathy and age-related macular degeneration (AMD).
This Special Issue will feature the latest developments and challenges in the diagnosis and management of retinal diseases. The topics covered in this issue include, but are not limited to, the following:
- The application of OCT and OCT angiography for the screening, diagnosis, and monitoring of retinal diseases.
- The advances in the treatment of retinal diseases, including wet and dry AMD, diabetic retinopathy, and inherited retinal diseases.
We invite original research articles and reviews that highlight the current state of the art and future directions in the field of retinal diagnostics. We hope that this Special Issue will provide a valuable resource for clinicians, researchers, and patients interested in retinal diseases.
Dr. Antonio Yaghy
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- optical coherence tomography (OCT)
- optical coherence tomography angiography (OCTA)
- wide-field imaging
- retinal diseases
- age-related macular degeneration
- diabetic retinopathy
- inherited retinal diseases
- medical diagnosis
- clinical trials
